Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-02963-ySource: DataRank Database

Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance is a research paper published in Cancer Immunology Immunotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.88)OA: greenTopics (66)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Kee Kiat Yeo ORCID,Sakunthala Muthugounder,Meng-Hua Lee,Cham Jung,Tania Porras-Corredor

Live enrichment

PubMed:34043024 PMC:PMC10991857 OpenAlex:https://openalex.org/W3164659665

National Institutes of Health

Grant: T32 CA009659

National Cancer Institute

Grant: P01 CA217959

DOD Peer Reviewed Cancer Research Program

Grant: CA170257P1

National Institutes of Health

Grant: 5T32CA009659-10

TRAINING IN BASIC RESEARCH IN ONCOLOGY

National Institutes of Health

Grant: 7P01CA217959-04

Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance

T.J. Martell Foundation

V Foundation for Cancer Research

Nautica Malibu Triathlon

FWCI

1.88

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10991857

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-021-02963-y.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-021-02963-y/fulltext.html

journalhttps://doi.org/10.1007/s00262-021-02963-y

Fields of Study

Neuroblastoma Research and TreatmentsCancer therapeutics and mechanismsLung Cancer Research Studies0301 basic medicine0303 health sciences03 medical and health sciences0302 clinical medicineAntibodiesAntibodies, MonoclonalAntibody-Dependent Cell CytotoxicityCell Line, TumorDrug ResistanceEndocytosisFlow CytometryGangliosidesHumansImmunologic FactorsImmunotherapyKiller Cells, NaturalNeuroblastomaNeutrophils

MeSH Terms

AntibodiesAntibodies, MonoclonalAntibody-Dependent Cell CytotoxicityDrug ResistanceEndocytosisFlow CytometryGangliosidesHumansImmunologic FactorsImmunotherapyKiller Cells, NaturalNeuroblastomaNeutrophilsCell Line, Tumor

Keywords

Antibody-dependent cell-mediated cytotoxicityInternalizationAntibodyImmunotherapyFlow cytometryEndocytosisNeuroblastomaCell cultureCancer researchCytotoxicityImmunologyCellBiologyIn vitroImmune systemMonoclonal antibodyBiochemistryADCCAntibody InternalizationDisialogangliosideAnti-gd2NeutrophilsAntibody-Dependent Cell CytotoxicityDrug ResistanceAntibodies, MonoclonalAntibodiesKiller Cells, NaturalCell Line, TumorGangliosidesHumansImmunologic Factors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being